Clinical Trial Update: Reducing Neonatal Morbidity by Discontinuing Oxytocin During the Active Phase of 1st Stage of Labor [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether discontinuing oxytocin during the active phase of the first stage of labor reduces neonatal morbidity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Morbidity

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Neonatal Morbidity | Phase 4 | Status: COMPLETED